ESR2 and triple-negative breast carcinoma: 2)EGFR can modulate ERβ’s growth-promoting effects since it is also active in triple-negative breast cancer (TNBC) cell lines [92,93,94], therefore any change in the expression and activity of EGFR may lead to modulation of ERβ signaling.